Cryoport Inc. (CYRX)
NASDAQ: CYRX
· Real-Time Price · USD
6.00
0.05 (0.84%)
At close: May 30, 2025, 3:59 PM
6.01
0.08%
After-hours: May 30, 2025, 04:04 PM EDT
Cryoport Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 |
|---|---|---|---|---|
| Product Revenue | 74.72M | 103.4M | 103.54M | 23.4M |
| Product Revenue Growth | -27.73% | -0.14% | +342.55% | n/a |
| Service Revenue | 153.66M | 133.88M | 119.06M | 55.3M |
| Service Revenue Growth | +14.78% | +12.44% | +115.31% | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
|---|---|---|---|---|---|---|---|
| Americas Revenue | 126.37M | 127.21M | 128.21M | 120.27M | 49.55M | 28.8M | 17.88M |
| Americas Revenue Growth | -0.66% | -0.78% | +6.60% | +142.70% | +72.06% | +61.11% | n/a |
| Asia Pacific Revenue | 42.42M | n/a | n/a | n/a | 8.82M | 618K | 384K |
| Asia Pacific Revenue Growth | n/a | n/a | n/a | n/a | +1327.99% | +60.94% | n/a |
| Emea Revenue | 59.6M | n/a | n/a | n/a | n/a | n/a | 1.36M |
| Emea Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 24.19M | 37.06M | 37.65M | 31.19M | 38.3M | 33.59M | 36.02M | 38.8M | 33.24M | 32.63M | 30.23M | 30.56M | 26.62M | 27.59M | 23.9M | 24.69M | 21.39M | 26.25M | 14.48M | 9.03M | 7.11M | 4.74M | 15.34M | 6.1M | 5.1M | 4.44M | 4.43M | 4.52M | 3.65M | 3.6M | 3.25M | 3.03M | 2.77M | 2.84M | 2.74M | 2.63M | 3.06M | 2.84M | 2.16M | 2.03M | 1.98M |
| Selling, General, and Administrative Revenue Growth | -34.72% | -1.59% | +20.73% | -18.58% | +14.05% | -6.77% | -7.16% | +16.73% | +1.86% | +7.94% | -1.07% | +14.80% | -3.49% | +15.42% | -3.19% | +15.43% | -18.51% | +81.31% | +60.38% | +26.92% | +50.00% | -69.09% | +151.37% | +19.53% | +15.04% | +0.08% | -1.91% | +23.74% | +1.35% | +10.90% | +7.38% | +9.14% | -2.35% | +3.52% | +4.48% | -14.24% | +7.97% | +31.40% | +6.49% | +2.44% | n/a |
| Research and Development Revenue | n/a | 4.16M | 4.16M | 4.65M | 4.75M | 4.75M | 5.15M | 4.26M | 3.88M | 4.68M | 3.98M | 3.52M | 3.54M | 3.89M | 4.19M | 4.46M | 4.3M | 3.49M | 2.31M | 1.95M | 1.73M | 1.07M | 1.64M | 540.93K | 489.6K | 598.76K | 463.36K | 448.59K | 329.73K | 380.31K | 344.8K | 230.74K | 249.84K | 103.15K | 214.68K | 135.8K | 144.48K | 227.76K | 100.3K | 77.72K | 85K |
| Research and Development Revenue Growth | -100.00% | -0.05% | -10.53% | -2.23% | +0.06% | -7.82% | +20.85% | +9.98% | -17.13% | +17.37% | +13.15% | -0.45% | -9.03% | -7.14% | -6.14% | +3.67% | +23.18% | +51.14% | +18.77% | +12.33% | +62.00% | -34.80% | +203.28% | +10.49% | -18.23% | +29.22% | +3.29% | +36.05% | -13.30% | +10.30% | +49.43% | -7.65% | +142.22% | -51.95% | +58.09% | -6.01% | -36.57% | +127.09% | +29.04% | -8.57% | n/a |